ストックスクリーナーアプリを入手
2.32
7.91%
0.17
アフターアワーズ：
2.35
0.03
+1.29%
前日終値:
$2.15
開ける：
$2.39
24時間の取引高:
194.07K
Relative Volume:
0.99
時価総額：
$115.64M
収益：
-
当期純損益:
$-6.48M
株価収益率:
-16.93
EPS:
-0.137
ネットキャッシュフロー:
$-5.30M
1週間 パフォーマンス:
+13.17%
1か月 パフォーマンス:
-12.78%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$2.05
$2.39
1週間の範囲:
$1.86
$2.39
52週間の値動き範囲:
$1.86
$33.90
Polaryx Therapeutics Inc Stock (PLYX) Company Profile
名前
Polaryx Therapeutics Inc
セクター
電話
201-940-7236
住所
140 EAST RIDGEWOOD AVENUE, PARAMUS
Compare PLYX vs VRTX, REGN, ARGX, RVMD, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PLYX
Polaryx Therapeutics Inc
|
2.32 | 97.70M | 0 | -6.48M | -5.30M | -0.137 |
VRTX
Vertex Pharmaceuticals Inc
|
477.10 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
762.63 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
853.82 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
187.53 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
316.01 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Polaryx Therapeutics Inc Stock (PLYX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-27 | 開始されました | Maxim Group | Buy |
Polaryx Therapeutics Inc (PLYX) 最新ニュース
PLYX Initiates Coverage On by Lucid Capital Markets -- Rating Se - GuruFocus
PLYX Initiates Coverage On by Lucid Capital Markets -- Rating Set to Buy - GuruFocus
Lucid Capital initiates Polaryx stock with buy rating on rare disease therapy potential - Investing.com Canada
PLYX|Polaryx Therapeutics Ord Shs|Price:1.950|Chg%:-0.100 - TradingKey
Polaryx Therapeutics, Inc. Revenue Breakdown – NASDAQ:PLYX - TradingView
Polaryx Therapeutics Ord Shs (PLYX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Polaryx Therapeutics Ord Shs (PLYX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
PLYX|Polaryx Therapeutics Ord Shs|Price:2.050|Chg%:-0.060 - TradingKey
Polaryx Therapeutics, Inc. Revenue Breakdown – BOATS:PLYX - TradingView
Polaryx Therapeutics Announces Chief Medical Officer Resignation - The Globe and Mail
Polaryx Therapeutics, Inc. Files Form 8-K as Emerging Growth Company on NASDAQ (PLYX) – July 2026 - Minichart
Polaryx Therapeutics' Lisa Bollinger resigns as Chief Medical Officer - TradingView
Polaryx Therapeutics, Inc. Announces Resignation of Lisa Bollinger from Chief Medical Officer, Effective July 19, 2026 - marketscreener.com
Polaryx Therapeutics, Inc. Common Stock (NASDAQ: PLYX) Stock Price, News & Analysis - Kalkine
Polaryx Sets 2026 Virtual Annual Shareholder Meeting - TipRanks
Polaryx Therapeutics (PLYX) schedules 2026 virtual annual meeting and proposal deadline - Stock Titan
Polaryx Therapeutics sets 2026 annual shareholder meeting as virtual event - Bitget
Polaryx Therapeutics (PLYX) Edges Higher Amidst Narrow Trading RangeMedian Line - dars.gov.et
What is HC Wainwright's Forecast for PLYX Q2 Earnings? - MarketBeat
Polaryx Therapeutics (NASDAQ:PLYX) Downgraded by Wall Street Zen to "Sell" - MarketBeat
PLYX News Today | Why did Polaryx Therapeutics stock drop today? - MarketBeat
H.C. Wainwright initiates Polaryx Therapeutics stock with buy rating By Investing.com - Investing.com South Africa
H.C. Wainwright initiates Polaryx Therapeutics stock with buy rating - Investing.com
PLYX Initiates Coverage On Polaryx Therapeutics -- Price Target Set at $7.00 - GuruFocus
Polaryx Therapeutics Initiated at Buy by HC Wainwright & Co. - Moomoo
Investment firm H.C. Wainwright announced today the launch of initial coverage research on biopharmaceutical company Polaryx Therapeutics Inc. - Bitget
Polaryx Therapeutics (PLYX) Stock Analysis Report | Financials & Insights - Benzinga España
Operating cash flow per share of Polaryx Therapeutics, Inc. – FWB:1V8 - TradingView
Free cash flow per share of Polaryx Therapeutics, Inc. – FWB:1V8 - TradingView
Polaryx Therapeutics (PLYX) Surges 7.7%: Momentum Builds Above Key SupportInstitutional Sentiment - DonanımHaber
Polaryx Therapeutics (PLYX) Holds Steady Near Support as Technical Indicators Signal ConsolidationSector Sentiment - dars.gov.et
Enterprise value to EBIT forward of Polaryx Therapeutics, Inc. – NASDAQ:PLYX - TradingView
Enterprise value to revenue forward of Polaryx Therapeutics, Inc. – NASDAQ:PLYX - TradingView
Price to sales forward of Polaryx Therapeutics, Inc. – NASDAQ:PLYX - TradingView
Price to earnings forward of Polaryx Therapeutics, Inc. – NASDAQ:PLYX - TradingView
Polaryx Therapeutics, Inc. Actuals & Estimates (NASDAQ:PLYX) - TradingView
PLYX Forecast — Price Target — Prediction for 2027 - TradingView
PLYX Stock Rockets To Best Day Ever: Why Retail Traders Are Piling Into This Battered Biotech - Stocktwits
Polaryx Therapeutics Ord Shs (PLYX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Polaryx Therapeutics Ord Shs (PLYX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Polaryx Therapeutics Ord Shs (PLYX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Polaryx Therapeutics Ord Shs - TradingKey
Polaryx Therapeutics Ord Shs (PLYX) Institutional Confidence - TradingKey
Polaryx Therapeutics Inc (PLYX) Stock Price, Quote, News & History - Benzinga
Polaryx Therapeutics (PLYX) Holds Steady Near Support Amid Quiet TradingPullback Trade - DonanımHaber
Polaryx Therapeutics (PLYX) Short Interest & Short Float | Updated Jun 2026 - MarketBeat
Polaryx Therapeutics (PLYX) Faces Pressure After 6.7% Drop: Key Support Levels in FocusHead and Shoulders - newsline.com
Polaryx Therapeutics, Inc. Common Stock (PLYX) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
Polaryx Therapeutics (PLYX) Stock Chart and Price History 2026 - MarketBeat
Polaryx Therapeutics CEO’s Mstone buys $360,003 in PLYX stock By Investing.com - Investing.com Australia
Polaryx Therapeutics (PLYX) Insider Trading Activity 2026 - MarketBeat
Polaryx Therapeutics Inc (PLYX) 財務データ
収益
当期純利益
現金流量
EPS
Polaryx Therapeutics Inc (PLYX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Landis G. Michael | Chief Financial Officer |
Feb 18 '26 |
Buy |
2.79 |
2,867 |
7,991 |
228,225 |
2.44%
0.02%
大文字化:
|
ボリューム (24 時間):